Application of the surgical system in robot-assisted laparoscopic partial splenectomy for benign splenic lesions
10.3760/cma.j.cn113884-20250120-00023
- VernacularTitle:机器人辅助LPS在脾脏良性占位性疾病中的应用
- Author:
Jia GUO
1
;
Ji WANG
1
;
Hongqin MA
1
;
Li LIU
1
;
Yusheng DU
1
;
Wenxing ZHAO
1
Author Information
1. 徐州医科大学附属医院普通外科，徐州 221002
- Publication Type:Journal Article
- Keywords:
Robotic surgical procedures;
Benign tumor of spleen;
Partial splenectomy
- From:
Chinese Journal of Hepatobiliary Surgery
2025;31(8):616-620
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the efficacy and safety of da Vinci robot-assisted laparoscopic partial splenectomy (LPS).Methods:A retrospective review was conducted on 12 patients who underwent robot-assisted LPS for benign splenic lesions at the Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, between January 2021 and August 2024. Among the patients, 5 were males and 7 were females, aged 35(21, 58) years. The operation time, intraoperative blood loss, and other related indicators, as well as postoperative complications and follow-up conditions were reviewed.Results:Robot-assisted LPS was successfully performed in all patients, with no conversions to open surgery, achieving a 100% spleen preservation rate (12/12). The operative time was (168.92±44.64) min, and the intraoperative blood loss was 75 (50, 175) ml, with no intraoperative blood transfusions required. The duration of postoperative drainage tube placement was (3.92±1.44) d, and the postoperative hospital stay was (5.33±1.07) d. No complications, such as bleeding, surgical site effusion, or pancreatic fistula occurred in the 12 patients. Minimal pleural effusion was observed in four cases, which required no special treatment. All patients were followed up for at least 6 months. During the follow-up period, there were no occurrences of portal vein thrombosis, overwhelming post-splenectomy infection, recurrent thrombocytosis, or disease recurrence.Conclusion:Robot-assisted LPS is a safe and feasible surgical approach for benign splenic lesions, demonstrating favorable outcomes.
